[HTML][HTML] Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

B Zhou, P Perel, GA Mensah, M Ezzati - Nature Reviews Cardiology, 2021 - nature.com
High blood pressure is one of the most important risk factors for ischaemic heart disease,
stroke, other cardiovascular diseases, chronic kidney disease and dementia. Mean blood …

Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies

S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng… - Pharmacological …, 2021 - ASPET
The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in
maintaining multiorgan health and homeostasis. Endothelial functions in health include …

[HTML][HTML] COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection

S Beyerstedt, EB Casaro, ÉB Rangel - European journal of clinical …, 2021 - Springer
COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. Angiotensin-
converting enzyme 2 (ACE2) is not only an enzyme but also a functional receptor on cell …

Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities

LA Bienvenu, J Noonan, X Wang… - Cardiovascular …, 2020 - academic.oup.com
The high mortality rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
infection is a critical concern of the coronavirus disease 2019 (COVID-19) pandemic …

[HTML][HTML] Natural history of COVID-19 and current knowledge on treatment therapeutic options

WG Dos Santos - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Despite intense research there is currently no effective vaccine available against the new
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …

Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications

JR Rey, J Caro‐Codón, SO Rosillo… - European journal of …, 2020 - Wiley Online Library
Aims Data on the impact of COVID‐19 in chronic heart failure (CHF) patients and its
potential to trigger acute heart failure (AHF) are lacking. The aim of this work was to study …

[HTML][HTML] Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence

M Treskova-Schwarzbach, L Haas, S Reda, A Pilic… - BMC medicine, 2021 - Springer
Background This study applies an umbrella review approach to summarise the global
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …

Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies

Y Mahamat-Saleh, T Fiolet, ME Rebeaud, M Mulot… - BMJ open, 2021 - bmjopen.bmj.com
Objectives We conducted a systematic literature review and meta-analysis of observational
studies to investigate the association between diabetes, hypertension, body mass index …

Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI

G De Luca, M Verdoia, M Cercek, LO Jensen… - Journal of the American …, 2020 - jacc.org
Background The fear of contagion during the coronavirus disease-2019 (COVID-19)
pandemic may have potentially refrained patients with ST-segment elevation myocardial …